Susan D. DeVore, a director at Elevance Health (NYSE: ELV), made one open market purchase of company shares worth about $375,000 in the last year. Her most recent buy occurred on August 19, 2025. This activity ranks her 1,032nd among nearly 5,000 individual insiders by purchase value, below the average of $1.5 million across 3.29 transactions per insider. She reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 27, 2026 | Solventum Corp | $SOLV | DeVore Susan D. | Director | M | Common Stock | 1980 | $0.00 | 5,544.0000 | 175,400,000 | 55.56% | 0.00% |
| March 27, 2026 | Solventum Corp | $SOLV | DeVore Susan D. | Director | M | Restricted Stock Units | 1980 | $0.00 | 0.0000 | 175,400,000 | 100.00% | 0.00% |
| Aug. 19, 2025 | Elevance Health, Inc. | $ELV | DeVore Susan D. | Director | P | Common Stock | 1200 | $312.15 | 3,502.0000 | 232,900,000 | 52.13% | 0.00% |
| May 22, 2025 | Unum Group | $UNM | DeVore Susan D. | Director | A | Common Stock | 2198 | $0.00 | 29,594.0000 | 188,069,200 | 8.02% | 0.00% |
| May 14, 2025 | Elevance Health, Inc. | $ELV | DeVore Susan D. | Director | A | Common Stock | 601 | $0.00 | 2,302.0000 | 232,900,000 | 35.33% | 0.00% |
| May 13, 2025 | Solventum Corp | $SOLV | DeVore Susan D. | Director | M | Common Stock | 3564 | $0.00 | 3,564.0000 | 173,700,000 | 9999.99% | 0.00% |
| May 13, 2025 | Solventum Corp | $SOLV | DeVore Susan D. | Director | M | Restricted Stock Units | 3564 | $0.00 | 0.0000 | 173,700,000 | 100.00% | 0.00% |
| April 30, 2025 | Solventum Corp | $SOLV | DeVore Susan D. | Director | A | Restricted Stock Units | 3403 | $0.00 | 3,403.0000 | 173,700,000 | 9999.99% | 0.00% |
| March 3, 2025 | Unum Group | $UNM | DeVore Susan D. | Director | S | Common Stock | 4423 | $81.21 | 27,396.0000 | 188,069,200 | 13.90% | 0.00% |
| March 3, 2025 | Unum Group | $UNM | DeVore Susan D. | Director | S | Common Stock | 5577 | $80.62 | 31,819.0000 | 188,069,200 | 14.91% | 0.00% |
| May 23, 2024 | Unum Group | $UNM | DeVore Susan D. | Director | A | Common Stock | 3342 | $0.00 | 37,396.0000 | 197,602,000 | 9.81% | 0.00% |
| May 15, 2024 | Elevance Health, Inc. | $ELV | DeVore Susan D. | Director | A | Common Stock | 388 | $0.00 | 1,701.0000 | 237,400,000 | 29.55% | 0.00% |
| May 13, 2024 | Solventum Corp | $SOLV | DeVore Susan D. | Director | A | Restricted Stock Units | 1980 | $0.00 | 5,544.0000 | 172,700,000 | 55.56% | 0.00% |
| May 13, 2024 | Solventum Corp | $SOLV | DeVore Susan D. | Director | A | Restricted Stock Units | 3564 | $0.00 | 3,564.0000 | 172,700,000 | 9999.99% | 0.00% |
| May 25, 2023 | Unum Group | $UNM | DeVore Susan D. | Director | A | Common Stock | 3839 | $0.00 | 34,054.0000 | 202,109,400 | 12.71% | 0.00% |
| May 10, 2023 | Elevance Health, Inc. | $ELV | DeVore Susan D. | Director | A | Common Stock | 457 | $0.00 | 1,313.0000 | 242,800,000 | 53.39% | 0.00% |